Searchable abstracts of presentations at key conferences in endocrinology

ea0034p9 | Bone | SFEBES2014

Pre-operative localisation studies in primary hyperparathyroidism: concordance with surgical findings and histology

McKeever Edward , Kennedy Robert , Kirk Stephen , Harper Roy , McLaughlin Darren , Mulligan C , Lynch Tom , Majury Clive , McHenry CM

Successful minimally invasive parathyroidectomy for primary hyperparathyroidism depends on accuracy of pre-operative localisation studies. Ultrasound (US) and sestimibi (SM) scanning remain the imaging modalities of choice reserving MRI, CT and PET for patients who have not been cured by previous explorations or for whom other localization techniques are uninformative or discordant. The aim of this study was to review the accuracy of US and SM in the pre-operative localisation...

ea0033p44 | (1) | BSPED2013

Mealtime insulin carbohydrate ratios and intensive insulin therapy

Kershaw Melanie , Jones Simon , Krone Ruth E , Krone Nils , Shaw Nicholas , Kirk Jeremy , Drummond Lesley , Barrett Timothy

Background: Our practice is to commence newly diagnosed children and young people (CYP) with diabetes, over 5 years old, on multiple daily insulin (MDI), using fixed Insulin to Carbohydrate ratios (ICRs) with meals across the day. ICRs are subsequently adjusted according to blood glucose response, individualising insulin treatment. We know intensified insulin therapy includes use of varied ICRs, reflecting varying insulin sensitivity at different times of day. We do not know w...

ea0031p139 | Cytokines and growth factors | SFEBES2013

IGF binding protein-2 is associated with all-cause and cardiovascular mortality in type 2 diabetes

Narayanan Ram Prakash , Oliver Robert L , Siddals Kirk W , Heald Adrian H , Ollier William E R , Gibson J Martin

Low IGFBP2 is associated with the metabolic syndrome, but high IGFBP2 is longitudinally associated with worsening renal function. IGFBP2 binds IGF2 (and IGF1) and modified IGF bioavailablilty. The aim of our study was to identify whether baseline IGFBP2 concentrations were associated with all-cause and cardiovascular mortality in type 2 diabetes.554 subjects (59.3% male, mean age 63.7 (S.D. 10.7)) with type 2 diabetes from the Salford Diab...

ea0030oc2.7 | Oral Communications 2 | BSPED2012

Growth, GH–IGF1 status and response to r-hGH therapy in 3-M syndrome, related to mutation status

Sakhinia Faezeh , Hanson Dan , Murray Philip , Kirk Jeremy , Cole Trevor , Skae Mars , Banerjee Indi , Padidela Raja , Patel Leena , Clayton Peter

Background: 3-M syndrome is associated with severe proportionate pre- and postnatal growth restriction, and is caused by mutations in CUL7, OBSL1, or CCDC8 genes.Aims and methods: To define baseline growth and GH–IGF1 axis status as well as response to r-hGH in relation to mutation status in 3-M children, using retrospective analysis of data from clinical notes.Results: 50 individuals (19 CUL7, 19 <...

ea0028p129 | Cytokines and growth factors | SFEBES2012

Circulating IGF-II concentration is associated with longitudinal increase in high density lipoprotein cholesterol in Type 2 diabetes

Narayanan Ram , Anderson Simon , Fu Bo , Hudson Julie , Oliver Rob , Siddals Kirk , Payton Anthony , Heald Adrian , Ollier William , Gibson John

Associations of Insulin-like growth factor-II with cardiovascular risk have been inadequately studied. We studied longitudinal associations of IGF-II with cardiovascular risk factors in people with type 2 diabetes. Subjects and methods: 462 type-2 diabetes patients aged 26 to 86 years from the Salford Diabetes cohort were analysed. Longitudinal clinical information was extracted (years 2002–2009) from an integrated database of primary care and hospital data. IGF-II was me...

ea0028p130 | Cytokines and growth factors | SFEBES2012

Polymorphisms of the IGFBP3 gene influence circulating IGF-II concentration in type 2 diabetes

Narayanan Ram , Siddals Kirk , Oliver Rob , Hudson Julie , Anderson Simon , Payton Anthony , Heald Adrian , Ollier William , Gibson John

Insulin-like growth factors have fundamental roles in metabolism and apoptosis. Circulating IGF-I and IGF-II are primarily sequestrated with IGFBP-3 in ternary complexes with the acid-labile subunit. We hypothesized that polymorphisms of the IGFBP3 gene may impact circulating IGF-II concentrations.Methods: 478 Caucasian patients were selected from the Salford Diabetes Cohort for analysis. Thirteen haplotype tagging single nucleotide polymorphisms (SNPs) ...

ea0027oc4.4 | Oral Communications 4 | BSPED2011

Natural history of background retinopathy in children and young people with diabetes

Karthikeyan Ambika , Dhillon Navpreet , Castle Andrew , Dodson Paul , Hogler Wolfgang , Kirk Jeremy , Krone Nils , Nolan Jacky , Barrett Tim

Aim: To describe the prevalence and natural history of retinopathy in a cohort of children and young people with type 1 diabetes attending a tertiary hospital diabetes clinic.Methods: We analysed follow-up data from 2008 to 2010 on all children eligible for retinopathy screening using the ‘Twinkle’ diabetes database and the regional retinal screening database.Results: 88% (149/169) of eligible children were screened in 20...

ea0027p83 | (1) | BSPED2011

Galactokinase deficiency in a patient with congenital hyperinsulinism: the cautionary tale of using bedside blood glucose monitors

Bayarchimeg Mashbat , Ismail Dunia , Lam Amanda , Burk Derek , Kirk Jeremy , Hogler Wolfgang , Flanaghan Sarah , Ellard Sian , Hussain Khalid

Background: Galactokinase catalyses the first committed step in galactose metabolism, the conversion of galactose to galactose-1-phosphate. Galactokinase deficiency is an extremely rare form of galactosaemia and the most frequent complication reported is cataracts. Congenital hyperinsulinism (CHI) is a cause of severe hypoglycaemia in the newborn period.Aims: To report the diagnostic pitfalls with bedside blood glucose testing in a neonate with combined ...

ea0024op1.4 | (1) | BSPED2010

Differences in metabolic effects of twice daily versus multiple daily insulin injections in children with type 1 diabetes

Abid N , Buckley G , Porter L , Day E , Davies P , Shaw N , Kirk J , Krone N , Hogler W , Barrett T

Introduction: Two insulin regimes are commonly used in type 1 diabetes (T1D): twice daily (BD) premixed insulin (short and intermediate acting), and multiple daily injections (MDI) of short acting insulin with once daily bolus of long acting insulin. MDI is associated with better glucose control in adults, but the evidence base is weaker for children.Objectives: We aimed to compare children started on MDI to BD from diagnosis, on HbA1c as a measure of gl...

ea0017p24 | (1) | BSPED2008

Characterisation of seven novel 11β-hydroxylase (CYP11B1) gene mutations: three severe and four mild mutations

Parajes S , Loidi L , Rumsby G , Kirk J , Cole T , Conway G , Quinkler M , Dominguez F , Arlt W , Krone N

Congenital adrenal hyperplasia (CAH) is one of the most common autosomal recessive disorders. About 5–8% of cases are caused by the deficiency of steroid 11β-hydroxylase (CYP11B1) due to mutations in CYP11B1 gene. CYP11B1-inactivating mutations can be found without particular hot-spot spread over the entire gene. A good phenotype-genotype correlation exists for the patients suffering from 11β-hydroxylase deficiency (11OHD). The prediction of diseas...